International Stem Cell Corporation
ISCO
$0.115
$0.02527.78%
| Weiss Ratings | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D | |||
| Rating Factors | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.71% | |||
| 30-Day Total Return | 26.37% | |||
| 60-Day Total Return | -10.85% | |||
| 90-Day Total Return | 64.29% | |||
| Year to Date Total Return | 26.37% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -41.03% | |||
| 52-Week Low % Change | 120.73% | |||
| Price | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.20 | |||
| 52-Week Low Price | $0.05 | |||
| 52-Week Low Price (Date) | Jul 01, 2024 | |||
| 52-Week High Price (Date) | Dec 20, 2024 | |||
| Valuation | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 920.50K | |||
| Enterprise Value | 7.79M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.08 | |||
| Earnings Per Share Growth | -615.65% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.11 | |||
| Price/Book (Q) | -0.23 | |||
| Enterprise Value/Revenue (TTM) | 0.91 | |||
| Price | $0.12 | |||
| Enterprise Value/EBITDA (TTM) | -22.72 | |||
| Enterprise Value/EBIT | -14.35 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 8.00M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 760 940 6383 | |||
| Address | 9745 Businesspark Avenue San Diego, CA 92131 | |||
| Website | www.internationalstemcell.com | |||
| Country | United States | |||
| Year Founded | 2001 | |||
| Profitability | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -6.36% | |||
| Profit Margin | -7.95% | |||
| Management Effectiveness | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -6.27% | |||
| Return on Equity | -- | |||
| Income Statement | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 8.53M | |||
| Total Revenue (TTM) | 8.53M | |||
| Revenue Per Share | $1.07 | |||
| Gross Profit (TTM) | 4.89M | |||
| EBITDA (TTM) | -343.00K | |||
| EBIT (TTM) | -543.00K | |||
| Net Income (TTM) | -678.00K | |||
| Net Income Avl. to Common (TTM) | -678.00K | |||
| Total Revenue Growth (Q YOY) | 10.44% | |||
| Earnings Growth (Q YOY) | 4.58% | |||
| EPS Diluted (TTM) | -0.08 | |||
| EPS Diluted Growth (Q YOY) | 4.88% | |||
| Balance Sheet | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.31M | |||
| Cash Per Share (Q) | $0.16 | |||
| Total Current Assets (Q) | 3.49M | |||
| Total Preferred Equity (Q) | 4.31 | |||
| Total Equity (Q) | 259.00K | |||
| Current Ratio (Q) | 0.740 | |||
| Book Value Per Share (Q) | -$0.51 | |||
| Total Assets (Q) | 5.18M | |||
| Total Current Liabilities (Q) | 4.72M | |||
| Total Debt (Q) | 3.88M | |||
| Total Liabilities (Q) | 4.92M | |||
| Total Common Equity (Q) | -4.05M | |||
| Cash Flow | ISCO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -171.00K | |||
| Cash from Financing (TTM) | -200.00K | |||
| Net Change in Cash (TTM) | -123.00K | |||
| Levered Free Cash Flow (TTM) | 194.10K | |||
| Cash from Operations (TTM) | 248.00K | |||
